Delivery Order SPE2DB20D2104-SPE2DB25FMFKW

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $15,793.76, is for the supply of XELJANZ XR 11 MG tablets. The order has a completion date of May 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XELJANZ XR 11 MG TABLET, a specialty pharmaceutical product, and has a ceiling value of $3,472.13. The contract is a firm fixed price agreement and has an ultimate completion date of July 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Xeljanz 5 mg tablets. The delivery order has a ceiling value of $7,534.98 and is a firm-fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 mg tablets. The contract has a ceiling value of $50,250.67 and a period of performance through November 27, 2024. It is a firm fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET. The contract has a firm fixed price of $30,050.50 and a completion date of January 17, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,839.84, is for the delivery of the drug XELJANZ 5 MG TABLET UU 60S. It is a firm fixed-price contract with an ultimate completion date of October 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the purchase of XELJANZ 5 MG tablets. The $2,839.84 firm-fixed price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 for delivering a range of medical commodities to support military healthcare programs. This delivery order...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $23,812.21 awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product, with a completion date of February 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,630.35, is for the supply of Xeljanz 5 mg tablets. It is a Firm Fixed Price contract with a completion date of May 15, 2024. The contract is not designated as a set-aside. AmerisourceBergen is the prime contractor and holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,035.38, is for the supply of XELJANZ XR 11 MG TABLET medical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMFKW
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xeljanz 5 mg tablets. The $4,640.23 firm-fixed-price contract has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order falls under that larger IDC. The contract does not have a set-aside designation, indicating open competition. As a leading pharmaceutical distributor, AmerisourceBergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 4/7/25, 10:42 AM